2BR-21244-01315
3 vaccinations
0 coded responses
19 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 160 / PA
- Registered
- 2020-12-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-21
Registered in v-safe
-
2020-12-21
Dose 1 — Pfizer-BioNTech
- 2020-12-21
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2020-12-28
- 2021-01-04
-
2021-01-11
Dose 2 — Pfizer-BioNTech
- 2021-01-18
- 2021-01-25
- 2021-02-08
- 2021-02-17
- 2021-02-24
- 2021-04-14
- 2021-07-12
-
2021-09-25
Dose 3 — Pfizer-BioNTech
-
2021-09-26
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-09-27
- 2021-09-28
- 2021-10-01
- 2021-10-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-11 | Pfizer-BioNTech | |
| 3 | 2021-09-25 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.